Apricus Biosciences (APRI) Misses Q4 EPS by 1c

Apricus Biosciences (NASDAQ: APRI) reported Q4 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• SanDisk upgraded at JPMorgan after investor day; shares climb